Ex Parte MALHOTRA - Page 10




              Appeal No. 1998-0189                                                                                          
              Application 08/196,933                                                                                        



              lines 31-33; and column 13, lines 4-7.  Taylor teaches that the alkaline processing                           
              composition is usually applied to a photoexposed diffusion transfer film unit.  The                           
              composition permeates the emulsion layers of the transfer film unit  to initiate                              
              development of the latent images therein. Column 12, lines 8-11; and column 13,                               
              lines 22-26.                                                                                                  
                     Both the examiner and the appellant ignore the fact that the processing                                
              composition relied on by the examiner for the bases of her rejection is in the form of a                      
              liquid.  The examiner has not explained how such a liquid composition would be suitable                       
              for receiving printed images, let alone rapidly absorbing images of an aqueous (liquid)                       
              ink.                                                                                                          
                     Accordingly, we find that the examiner has failed to establish a prima facie case                      
              of anticipation.  Rejection (6) is reversed.                                                                  







                            NEW GROUND OF REJECTION UNDER 37 C.F.R. § 1.196(b)                                              
                     We enter the following new grounds of rejection regarding the elected species                          
              “pyrimidine” under the provisions of 37 C.F.R. § 1.196(b).  We have not considered  the                       
              patentability of the other claimed species.                                                                   
                                                            10                                                              





Page:  Previous  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  Next 

Last modified: November 3, 2007